<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02034136</url>
  </required_header>
  <id_info>
    <org_study_id>DH-13722</org_study_id>
    <secondary_id>BD2013-104</secondary_id>
    <nct_id>NCT02034136</nct_id>
  </id_info>
  <brief_title>Ginsenoside Improve Metabolic Syndrome</brief_title>
  <official_title>Effects of Ginsenoside Supplementation on Insulin Resistance and Cardiometabolic Risk Factors in Men With Metabolic Syndrome: a Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHA University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Korean Society of Ginseng</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>CHA University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim : Investigated the effects of Korean red ginseng supplementation on metabolic parameters
      such as cholesterol, blood pressure and glucose.

      Randomized Control Trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods : A randomized, double-blind, placebo-controlled, single-center study in 60 subjects
      who are not taking drugs that could affect metabolic and vascular function. Subjects will be
      randomized into a Korean red ginseng (3.0g/d) group or placebo group for a 4-week study.

      We will collect anthropometric measurements, blood for laboratory testing, inflammatory
      marker, hormones and mitochondrial DNA copy number.

      Subject : Older than 40 years of age, presented with metabolic syndrome. Subjects were
      excluded if they were taking drugs that could affect metabolic and vascular function,
      including BP control drug, anti-diabetic drugs and lipid-lowering drugs.

      Measurement : We will collect anthropometric measurements and blood for laboratory testing at
      the initial(week 0) and final (week 4)visits. Serum levels of blood glucose, insulin, total
      cholesterol, HDL-cholesterol,triglyceride, and DNA copy number of mitochondria.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in metabolic syndrome profile at week 4</measure>
    <time_frame>Baseline and 4 weeks from intake of Ginsenoside</time_frame>
    <description>Total cholesterol, HDL-Cholesterol, Glucose, Blood Pressure, Body weight</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in hormones at week 4.</measure>
    <time_frame>Initial and 4 weeks later</time_frame>
    <description>insulin ,cortisol, testosterone, somatomedin-c and DHEAS</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Mitochondria DNA copy number</measure>
    <time_frame>initial and 4 weeks later</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Ginsenoside</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ginsenoside :
Intervention : ginsenoside, 3 gram / day, for 28 days in intervention group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietary fiber fill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dietary fiber fill manufactured to mimic Ginsenoside tablet</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ginsenoside</intervention_name>
    <description>3.0 g/ d for 28 days</description>
    <arm_group_label>Ginsenoside</arm_group_label>
    <other_name>Ginseng fill</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary fiber fill</intervention_name>
    <description>3g/day, 28days</description>
    <arm_group_label>Dietary fiber fill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  metabolic syndrome

        Exclusion Criteria:

          -  Taking drug for lipid-lowering, BP control and anti-diabetic.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>DH Jung, MPH.M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cha Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>DH Jung, MPH</last_name>
    <phone>+82) 10-4204-8998</phone>
    <email>balsan2@empas.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>YJ Lee, Ph.D</last_name>
    <phone>+82) 3015-2011</phone>
    <email>ykyjhome@yuhs.ac</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bundang CHA Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Kyeonggi-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>HG Park, PhD</last_name>
      <email>irb@chamc.co.kr</email>
    </contact>
    <investigator>
      <last_name>DH Jung, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://www.ginsengsociety.org/</url>
    <description>The goal of Korean ginsengsociety is to help elevate the level of ginseng science in both theory and practice by providing technical information to the ginseng industry, providing ginseng-related education to the community.</description>
  </link>
  <reference>
    <citation>Park BJ, Lee YJ, Lee HR, Jung DH, Na HY, Kim HB, Shim JY. Effects of Korean Red Ginseng on Cardiovascular Risks in Subjects with Metabolic Syndrome: a Double-blind Randomized Controlled Study. Korean J Fam Med. 2012 Jul;33(4):190-6. doi: 10.4082/kjfm.2012.33.4.190. Epub 2012 Jul 25.</citation>
    <PMID>22916320</PMID>
  </reference>
  <reference>
    <citation>Rasheed N, Tyagi E, Ahmad A, Siripurapu KB, Lahiri S, Shukla R, Palit G. Involvement of monoamines and proinflammatory cytokines in mediating the anti-stress effects of Panax quinquefolium. J Ethnopharmacol. 2008 May 8;117(2):257-62. doi: 10.1016/j.jep.2008.01.035. Epub 2008 Feb 8.</citation>
    <PMID>18339495</PMID>
  </reference>
  <reference>
    <citation>Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman AT, Penninx BW. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry. 2013 Jun;18(6):692-9. doi: 10.1038/mp.2012.144. Epub 2012 Oct 23.</citation>
    <PMID>23089630</PMID>
  </reference>
  <reference>
    <citation>Yun SN, Ko SK, Lee KH, Chung SH. Vinegar-processed ginseng radix improves metabolic syndrome induced by a high fat diet in ICR mice. Arch Pharm Res. 2007 May;30(5):587-95.</citation>
    <PMID>17615678</PMID>
  </reference>
  <reference>
    <citation>Kim JH, Lee DC. Mitochondrial DNA copy number in peripheral blood is associated with femoral neck bone mineral density in postmenopausal women. J Rheumatol. 2012 Jul;39(7):1465-72. doi: 10.3899/jrheum.111444. Epub 2012 May 15.</citation>
    <PMID>22589267</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2013</study_first_submitted>
  <study_first_submitted_qc>January 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2014</study_first_posted>
  <last_update_submitted>January 10, 2014</last_update_submitted>
  <last_update_submitted_qc>January 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>CHA University</investigator_affiliation>
    <investigator_full_name>Dong-Hyuk Jung</investigator_full_name>
    <investigator_title>Assistant professor, Family medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

